Skin deep? At Estée Lauder, beauty science runs deeper
By TOM MARINER // Of course you know the multinational powerhouse, but that’s not how The Estée Lauder Companies began. Queens-born Estée Lauder and her husband, Joseph, launched the small…
Pharmaceuticals
A history of compliance with cornerstone LI consultancy
By TOM MARINER // The U.S. Food and Drug Administration regulates 2 million medical devices and a $1.6 trillion pharmaceuticals industry, all with a nod to a longtime Long Island…
With $150M ante, Albany all-in on LI’s BioGenesis Park
By GREGORY ZELLER // A whopping nine-digit state investment will spark a groundbreaking Cell and Gene Therapy innovation hub on Long Island. Albany is anteing up $150 million – including…
State nod marks another win for ‘precision medication’
By GREGORY ZELLER // An accomplished Long Island biotech with a penchant for polymerase chain reaction-based DNA technologies has earned state approvals for a cutting-edge pharmacogenomic testing service. Pharmacogenomics, the…
Fifty years and one full circle at Contract Pharmacal
By TOM MARINER // A familiar theme for success – and for staying on Long Island – is “family owned and operated.” Look no further than Contract Pharmacal Corp., which…
Aceto adds to its chemistry set with latest acquisition
By GREGORY ZELLER // A leading “virtual manufacturer” for the life sciences and advanced-technology markets has completed another key takeover. Port Washington-based Aceto Corp., a top global provider of industrial…
With synthetic opioids lurking, DNA detector scores
By GREGORY ZELLER // With synthetic opioids increasingly implicated in the alarming number of drug-overdose deaths plaguing the nation, a stalwart Long Island biotech’s DNA-based tracking technology has received a…
Stakeholders unite to support pharma/nutra’s future
By GREGORY ZELLER // With more than 150 companies and 9,800-plus employees, the pharmaceutical/nutraceutical industry is already a Long Island cornerstone – and some major regional stakeholders want to see…
Memo to Applied DNA: It’s payday in Pennsylvania
By GREGORY ZELLER // Memorandums of understanding are swell and all, but for a scrappy enterprise forever waging a bottom-line battle, nothing beats getting paid. So, Stony Brook-based Applied DNA…
Pharm hand: Why Rechler Equity is big on biotech
By GREGORY ZELLER // Anyone still doubting the importance of the pharmaceutical and biotech industries to the Long Island economy should take a peek at Rechler Equity Partners’ portfolio. This…